Welcome to our dedicated page for Naturl Alt Intl SEC filings (Ticker: NAII), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Natural Alternatives International, Inc. (NAII) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. As a NASDAQ-listed issuer incorporated in Delaware, NAI submits annual reports on Form 10-K, quarterly reports on Form 10-Q, and current reports on Form 8-K, along with proxy materials such as the definitive proxy statement on Schedule 14A.
For a company in the nutritional supplements and medicinal and botanical manufacturing sector, Form 10-K and Form 10-Q are central sources of information on segment performance for private-label contract manufacturing and patent and trademark licensing, including CarnoSyn® beta-alanine royalty, licensing and raw material sales. These filings also describe factors affecting results, such as manufacturing costs, factory capacity utilization, and sales mix between segments.
Form 8-K current reports document material events. Recent examples include an amended credit facility with Wells Fargo Bank extending NAI’s revolving line of credit and adding collateral, a Waiver and Release Agreement in which Wells Fargo waived certain financial covenant defaults, and a Manufacturing Agreement with The Juice Plus+ Company covering Juice Plus+ products in 24 countries. Other 8-K filings summarize outcomes of the annual meeting of stockholders, including votes on director elections, amendments to equity incentive plans, and advisory votes on executive compensation.
NAI’s DEF 14A definitive proxy statement outlines governance matters, annual meeting logistics, and proposals submitted to shareholders, including board elections, equity plan amendments, auditor ratification, and advisory compensation votes. These materials help investors understand the company’s governance framework and shareholder voting results.
On Stock Titan, NAII filings are updated in near real time from EDGAR, and AI-powered summaries highlight the key points of lengthy documents such as 10-Ks, 10-Qs, and 8-Ks. Users can quickly see what changed in new filings, how credit agreements and manufacturing contracts are structured, and how shareholder approvals may affect equity plans and governance, without reading every page of the underlying documents.
Natural Alternatives International, Inc. (NASDAQ: NAII) filed an 8-K announcing the execution of a Sixth Amendment to its credit agreement with Wells Fargo, effective June 20, 2025.
Key terms
- Maturity extended from the current expiry to December 31, 2026, giving NAII an additional 18 months of committed bank financing.
- Revolving credit limit reduced from $12.5 million to $10 million, lowering undrawn liquidity head-room by $2.5 million.
- Collateral expanded: the company’s Carlsbad, CA powder-processing facility is now pledged, and the existing Deed of Trust is modified to secure both the term loan and the amended revolver.
- All other security agreements, including the July 1, 2019 Security Agreement, remain in force.
The amendment package consists of three executed documents (Exhibits 10.40-10.42) and is accompanied by a press release dated June 23, 2025 (Exhibit 99.9). No financial statements were included.
Management characterizes the change as a material definitive agreement (Item 1.01) and a direct financial obligation (Item 2.03). The filing provides no update on current borrowings, covenant levels or interest pricing.